About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Melanoma Clinical Trials in Maryland | 303 Studies

Clinical Trials MelanomaMaryland

Melanoma Clinical Trials in Maryland

Find 303 clinical trials for melanoma near Maryland. Connect with research centers in your area.

All Melanoma trials nationwide All trials in Maryland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 241-260 of 303 trials

CompletedVaccine Therapy in Treating Patients With Metastatic CancerRATIONALE: Vaccines made from a peptide may make the body build an immune response and kill tumor cells.NCT00021164·Bethesda, Maryland UnknownRandomized Trial of ATN-224 and Temozolomide in Advanced MelanomaThis is a multicenter, randomized, phase II study to evaluate the safety and efficacy of oral ATN-224 plus temozolomide in patients with advanced melanoma.NCT00383851·Tucson, Arizona and 16 others CompletedPyrazoloacridine in Treating Patients With Metastatic Skin or Eye MelanomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003802·Baltimore, Maryland

Melanoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingTalimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin CancersThis phase II trial studies how well talimogene laherparepvec and nivolumab work in treating patients with lymphomas that do not responded to treatment (refractory) or…NCT02978625·Los Angeles, California and 35 others

CompletedDovitinib for Patients With Tumor Pathway Activations Inhibited by DovitinibThe purpose of this signal seeking study was to determine whether treatment with dovitinib (TKI258) demonstrated sufficient efficacy in select pathway-activated solid tumors…NCT01831726·Birmingham, Alabama and 48 others

CompletedVaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic MelanomaRATIONALE: Vaccines made from peptides may make the body build an immune response to kill tumor cells.NCT00071981·Palo Alto, California and 64 others

CompletedImmunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic MelanomaBackground: * The National Cancer Institute (NCI) Surgery Branch has developed an experimental therapy that involves taking white blood cells from patients' tumors, growing them…NCT01993719·Bethesda, Maryland

CompletedMicroarray Analysis for Human Genetic DiseaseThis study will look at genetic changes which occur in the development of male and female breast cancer and other cancer.NCT00001898·Tucson, Arizona and 7 others

CompletedRecombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck CancerThis phase I trial studies the side effects and best dose of recombinant interleukin-15 in treating patients with melanoma, kidney cancer, non-small cell lung cancer, or head and…NCT01727076·Palo Alto, California and 4 others

TerminatedLapatinib in Stage IV Melanoma With ERBB4 MutationsBackground: \- Studies of melanoma tumor samples have shown that tumor cells from approximately 20 percent of melanoma patients contain a specific mutation of a gene involved in…NCT01264081·Bethesda, Maryland

CompletedRetrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics DataThis study is a retrospective one, exploring the hypothesis that a person's genotypic makeup may be associated with a clinical response or toxic effect to a drug.NCT00341939·Bethesda, Maryland

TerminatedVaccine Therapy With or Without Interleukin-2 After Chemotherapy and an Autologous White Blood Cell Infusion in Treating Patients With Metastatic MelanomaThis randomized phase II trial is studying how well giving vaccine therapy with or without interleukin-2 after chemotherapy and an autologous white blood cell infusion works in…NCT00303836·Bethesda, Maryland

CompletedRFT-5-dgA in Patients With Metastatic MelanomaBackground: * CD4+ cells are white blood cells that regulate the immune system by controlling the strength and quality of the immune response.NCT00314093·Bethesda, Maryland

TerminatedAdjuvant Tumor Lysate Vaccine and Iscomatrix With or Without Metronomic Oral Cyclophosphamide and Celecoxib in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or MediastinumBackground: During recent years, cancer-testis (CT) antigens (CTA), particularly those encoded by genes on the X chromosome (CT-X genes), have emerged as attractive targets for…NCT02054104·Bethesda, Maryland

CompletedAnti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic MelanomaThis Phase II study is designed to evaluate the anti-tumor activity of three dose groups of SB-485232 (0.01, 0.1, and 1.0 mg/kg/day) administered intravenously as a single agent…NCT00107718·Los Angeles, California and 19 others

CompletedAn Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have SpreadThe purpose of the study is to determine safety and effectiveness of experimental medication BMS-986205 when combined with Nivolumab and in combination with both Nivolumab and…NCT02658890·Tucson, Arizona and 46 others

TerminatedUse of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic MelanomaBackground: \- Researchers have developed an experimental cancer treatment called cell therapy.NCT01369888·Bethesda, Maryland

RecruitingSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryInternational registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool…NCT03452774·Birmingham, Alabama and 67 others

CompletedSafety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant MelanomaThe purpose of this study is to determine the safety, tolerability, pharmacokinetics and pharmacodynamics of GC1008, a human anti-transforming growth factor-beta (TGFβ) monoclonal…NCT00356460·Bethesda, Maryland and 5 others

RecruitingExcision of Lymph Node Trial (EXCILYNT) (Mel69)The purpose of this study is to find out if removing only the cancerous lymph node (known as a lymph node excision) is effective at preventing cancer from coming back in the same…NCT05839912·Atlanta, Georgia and 6 others

PreviousPage 13 of 16Next

Other Conditions in Maryland

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Leukemia Lymphoma